BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 27699213)

  • 1. Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.
    Federico G; Meister M; Mathow D; Heine GH; Moldenhauer G; Popovic ZV; Nordström V; Kopp-Schneider A; Hielscher T; Nelson PJ; Schaefer F; Porubsky S; Fliser D; Arnold B; Gröne HJ
    JCI Insight; 2016 Jan; 1(1):e84916. PubMed ID: 27699213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hormetic functions of Wnt pathways in tubular injury.
    Gröne EF; Federico G; Nelson PJ; Arnold B; Gröne HJ
    Pflugers Arch; 2017 Aug; 469(7-8):899-906. PubMed ID: 28685176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner.
    Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X
    Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue growth factor induces tubular epithelial to mesenchymal transition through the activation of canonical Wnt signaling in vitro.
    Yang Z; Sun L; Nie H; Liu H; Liu G; Guan G
    Ren Fail; 2015 Feb; 37(1):129-35. PubMed ID: 25296105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.
    Zewinger S; Rauen T; Rudnicki M; Federico G; Wagner M; Triem S; Schunk SJ; Petrakis I; Schmit D; Wagenpfeil S; Heine GH; Mayer G; Floege J; Fliser D; Gröne HJ; Speer T
    J Am Soc Nephrol; 2018 Nov; 29(11):2722-2733. PubMed ID: 30279273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of renal tubular Wnt/β-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathy.
    Wong DW; Yiu WH; Wu HJ; Li RX; Liu Y; Chan KW; Leung JC; Chan LY; Lai KN; Tang SC
    Cell Death Dis; 2016 Mar; 7(3):e2155. PubMed ID: 27010856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells.
    Luo C; Zhou S; Zhou Z; Liu Y; Yang L; Liu J; Zhang Y; Li H; Liu Y; Hou FF; Zhou L
    J Am Soc Nephrol; 2018 Apr; 29(4):1238-1256. PubMed ID: 29440280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Patterns of Kidney Fibrosis Are Indicative of Injury to Distinct Renal Compartments.
    Tampe D; Schridde L; Korsten P; Ströbel P; Zeisberg M; Hakroush S; Tampe B
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of TFEB-mediated autophagy to tubulointerstitial fibrosis in mice with adenine-induced chronic kidney disease.
    Yuan H; Zheng C; Zhu L; Song Z; Dai L; Hu Q; Wang L; Chen Y; Xiong J
    Biomed Pharmacother; 2021 Jan; 133():110949. PubMed ID: 33227703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
    Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
    Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubular atrophy in the pathogenesis of chronic kidney disease progression.
    Schelling JR
    Pediatr Nephrol; 2016 May; 31(5):693-706. PubMed ID: 26208584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition.
    Lipphardt M; Dihazi H; Jeon NL; Dadafarin S; Ratliff BB; Rowe DW; Müller GA; Goligorsky MS
    Nephrol Dial Transplant; 2019 Jan; 34(1):49-62. PubMed ID: 29726981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.
    Marchal PO; Kavvadas P; Abed A; Kazazian C; Authier F; Koseki H; Hiraoka S; Boffa JJ; Martinerie C; Chadjichristos CE
    PLoS One; 2015; 10(9):e0137876. PubMed ID: 26367310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
    Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
    Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dickkopf 3-a novel biomarker of the 'kidney injury continuum'.
    Schunk SJ; Speer T; Petrakis I; Fliser D
    Nephrol Dial Transplant; 2021 Apr; 36(5):761-767. PubMed ID: 32025732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin is an ubiquitous extracellular matrix protein of human renal interstitium in normal and pathologic conditions.
    Truong LD; Foster SV; Barrios R; D'Agati V; Verani RR; Gonzalez JM; Suki WN
    Nephron; 1996; 72(4):579-86. PubMed ID: 8730425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic exposure to nanoparticulate TiO2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney.
    Hong F; Hong J; Wang L; Zhou Y; Liu D; Xu B; Yu X; Sheng L
    J Agric Food Chem; 2015 Feb; 63(5):1639-47. PubMed ID: 25603832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury.
    Djudjaj S; Chatziantoniou C; Raffetseder U; Guerrot D; Dussaule JC; Boor P; Kerroch M; Hanssen L; Brandt S; Dittrich A; Ostendorf T; Floege J; Zhu C; Lindenmeyer M; Cohen CD; Mertens PR
    J Pathol; 2012 Nov; 228(3):286-99. PubMed ID: 22806125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.